Inhibition of 2-Amino-1-methyl-6-phenylimidazo[4,5]pyridine-induced lymphoma formation by oltipraz.

Author(s): Rao CV,  Rivenson A,  Zang E,  Steele V,  Kelloff G,  Reddy BS

Journal: Cancer Res

Date: 1996 Aug 1

Major Program(s) or Research Group(s): CADRG

PubMed ID: 8758900

PMC ID: not available

Abstract: 2-Amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is a mutagenic and carcinogenic heterocyclic amine present in pyrolysate products of meat and fish and has been shown to induce tumors in the colon, mammary gland, and possibly lymphatic system. Experiments were designed to examine the lymphoma-inducing capacity of PhIP and to test the inhibitory effects of oltipraz on PhIP-induced lymphomas in male F344 rats. Beginning at 5 weeks of age, groups of rats were fed the diets containing 0, 200, and 400 ppm oltipraz with or without 100-400 ppm PhIP. All animals were continued on this regimen until the 58th week. The results indicate that administration of PhIP produced lymphomas in 75% of rats. Most of the large lymphomas were thymomas (65%), and these lymphomas developed in less than 6 months. Death of animals during the course of the study was due to suffocation produced by a large lymphoma that filled the entire thoracic cavity, resulting in collapse of the lungs. Administration of 200-400 ppm oltipraz significantly protected rats from PhIP-induced toxicity; most of the rats survived until termination of the experiments. It is noteworthy that the addition of oltipraz at 200 and 400 ppm in the diet suppressed the PhIP-induced lymphomas to 90-100%. In conclusion, PhIP-induced lymphomas in the laboratory rat appears to be a very useful model to analyze the genesis of lymphomas, and oltipraz serves as a potential chemopreventive agent for lymphomas.